Phase 1 Cachexia Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
CachexiaLocally Advanced Cervical Cancer
Second Xiangya Hospital of Central South University88 enrolled1 locationNCT07338487
Recruiting
Phase 1
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
Cachexia
AVEO Pharmaceuticals, Inc.30 enrolled12 locationsNCT05865535
Recruiting
Phase 1
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia
Solid Tumor MalignanciesCachexia-Anorexia Syndrome
Jiangsu Nutai Biologics Co., Ltd54 enrolled1 locationNCT07231120
Recruiting
Phase 1
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants
Cancer CachexiaCancer Cachexia (CC)
Shenzhen Kexing Pharmaceutical Co., Ltd.36 enrolled1 locationNCT07237464
Recruiting
Phase 1
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
Cancer Cachexia
Genfleet Therapeutics (Shanghai) Inc.36 enrolled1 locationNCT06898255